Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEULAND LABS vs ELDER PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NEULAND LABS ELDER PHARMA NEULAND LABS/
ELDER PHARMA
 
P/E (TTM) x 24.6 -1.0 - View Chart
P/BV x 7.8 0.1 7,764.5% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 NEULAND LABS   ELDER PHARMA
EQUITY SHARE DATA
    NEULAND LABS
Mar-23
ELDER PHARMA
Jun-14
NEULAND LABS/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs2,004380 527.4%   
Low Rs966188 513.8%   
Sales per share (Unadj.) Rs928.4489.2 189.8%  
Earnings per share (Unadj.) Rs127.4-3.2 -4,008.3%  
Cash flow per share (Unadj.) Rs168.614.4 1,170.0%  
Dividends per share (Unadj.) Rs10.000-  
Avg Dividend yield %0.70-  
Book value per share (Unadj.) Rs774.8376.5 205.8%  
Shares outstanding (eoy) m12.8320.54 62.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.60.6 275.5%   
Avg P/E ratio x11.7-89.3 -13.0%  
P/CF ratio (eoy) x8.819.7 44.7%  
Price / Book Value ratio x1.90.8 254.1%  
Dividend payout %7.80-   
Avg Mkt Cap Rs m19,0525,832 326.6%   
No. of employees `000NANA-   
Total wages/salary Rs m2,0182,179 92.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m11,91210,048 118.6%  
Other income Rs m97257 38.0%   
Total revenues Rs m12,00910,305 116.5%   
Gross profit Rs m2,7182,921 93.1%  
Depreciation Rs m528361 146.1%   
Interest Rs m1312,756 4.7%   
Profit before tax Rs m2,15760 3,604.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m522125 417.3%   
Profit after tax Rs m1,635-65 -2,503.7%  
Gross profit margin %22.829.1 78.5%  
Effective tax rate %24.2209.1 11.6%   
Net profit margin %13.7-0.6 -2,112.0%  
BALANCE SHEET DATA
Current assets Rs m7,6099,240 82.3%   
Current liabilities Rs m4,3909,998 43.9%   
Net working cap to sales %27.0-7.5 -358.4%  
Current ratio x1.70.9 187.6%  
Inventory Days Days6128 5.0%  
Debtors Days Days1,109602 184.2%  
Net fixed assets Rs m8,18913,642 60.0%   
Share capital Rs m129206 62.7%   
"Free" reserves Rs m9,8127,528 130.3%   
Net worth Rs m9,9417,733 128.5%   
Long term debt Rs m7424,889 15.2%   
Total assets Rs m15,79822,882 69.0%  
Interest coverage x17.51.0 1,713.9%   
Debt to equity ratio x0.10.6 11.8%  
Sales to assets ratio x0.80.4 171.7%   
Return on assets %11.211.8 95.0%  
Return on equity %16.4-0.8 -1,947.8%  
Return on capital %21.422.3 96.0%  
Exports to sales %73.53.1 2,407.4%   
Imports to sales %15.10.4 3,530.6%   
Exports (fob) Rs m8,750307 2,854.0%   
Imports (cif) Rs m1,80443 4,185.8%   
Fx inflow Rs m8,750307 2,854.0%   
Fx outflow Rs m1,804125 1,440.2%   
Net fx Rs m6,946181 3,830.7%   
CASH FLOW
From Operations Rs m2,37211,754 20.2%  
From Investments Rs m-615-561 109.7%  
From Financial Activity Rs m-1,358-6,762 20.1%  
Net Cashflow Rs m4035,466 7.4%  

Share Holding

Indian Promoters % 32.8 25.3 129.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 29.1 24.0 121.4%  
FIIs % 22.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 67.2 74.7 90.0%  
Shareholders   27,723 31,548 87.9%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NEULAND LABS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on NEULAND LABS vs Elder Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

NEULAND LABS vs Elder Pharma Share Price Performance

Period NEULAND LABS Elder Pharma S&P BSE HEALTHCARE
1-Day -3.10% 4.97% -1.50%
1-Month -14.01% 21.21% -5.53%
1-Year 272.81% -64.54% 56.62%
3-Year CAGR 45.62% -51.65% 17.93%
5-Year CAGR 54.36% -37.46% 18.75%

* Compound Annual Growth Rate

Here are more details on the NEULAND LABS share price and the Elder Pharma share price.

Moving on to shareholding structures...

The promoters of NEULAND LABS hold a 32.8% stake in the company. In case of Elder Pharma the stake stands at 25.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of NEULAND LABS and the shareholding pattern of Elder Pharma.

Finally, a word on dividends...

In the most recent financial year, NEULAND LABS paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 7.8%.

Elder Pharma paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of NEULAND LABS, and the dividend history of Elder Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Tanks 735 Points | IT & FMCG Stocks Drag | 5 Reasons Why Indian Share Market is Falling Sensex Today Tanks 735 Points | IT & FMCG Stocks Drag | 5 Reasons Why Indian Share Market is Falling(Closing)

After opening the negative note, Indian share markets continued the downtrend as the session progressed and ended the day weak.